Abstract
CD30 is variably expressed in diffuse large B-cell lymphoma (DLBCL), but its prognostic potential for the affected patients remains debatable and unclear. Therefore, we aimed to determine the frequency of CD30 expression in DLBCL and its potential for prognostic determination. An electronic systematic review was performed using multiple databases, followed by a quantitative meta-analysis to assess the frequency of CD30 expression with positivity cut-off values of >0% and >20%, and to determine its association with clinicopathological features and patients' survival. Using a cut-off value >0%, we observed that 3.5%-59.1% of the cases were considered positive for CD30. There was a significant association of the protein expression with a lower number of extra-nodal sites affected by the neoplasm, with Ann Arbor advanced stage, the absence of B-symptoms, the lack of MYC and BCL2 translocations, and a lower ECOG performance. Using a cut-off value >20%, we observed that 2.5%-36.7% of the cases were considered positive for CD30, being significantly associated with a lower number of extra-nodal sites affected by the neoplasm, Ann Arbor stages III/IV, non-GCB tumours, the lack of MYC and BCL2 translocations, and a lower ECOG value. CD30...Continue Reading
References
Sep 25, 2003·Blood·Christine P HansWing C Chan
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
Jan 25, 2013·Blood·Shimin HuKen H Young
Sep 7, 2013·Acta Haematologica·S Al-HumoodB Al-Ayadhy
Mar 4, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chi Young OkKen H Young
Aug 20, 2014·British Journal of Haematology·Graham W SlackRandy D Gascoyne
Jan 13, 2015·Blood·Eric D JacobsenNancy L Bartlett
May 15, 2015·PloS One·Xiaoxiao HaoRu Feng
Jul 30, 2015·PloS One·Chen-Ge SongZhi-Ming Li
Sep 6, 2015·European Journal of Haematology·Xuan J WangShaoying Li
Feb 26, 2016·Clinical Lymphoma, Myeloma & Leukemia·Morton ColemanIra A Jacobs
Nov 7, 2016·Human Pathology·Jie XuShaoying Li
Nov 22, 2016·Leukemia & Lymphoma·Nancy L BartlettEric D Jacobsen
Dec 9, 2016·Expert Review of Hematology·John Matthew R Pierce, Amitkumar Mehta
Feb 13, 2017·Drugs·Lesley J Scott
Dec 28, 2017·Journal of Clinical and Experimental Hematopathology : JCEH·Naoko TsuyamaKengo Takeuchi
Apr 19, 2018·Journal of Clinical Pathology·Qi-Xing GongZhi-Hong Zhang
Jul 10, 2018·American Journal of Hematology·Jorge J CastilloEduardo M Sotomayor
Nov 11, 2018·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Carla Isabelly Rodrigues-FernandesFelipe Paiva Fonseca
Mar 13, 2019·American Journal of Hematology·Yang Liu, Stefan Klaus Barta
Jun 1, 2019·Expert Review of Hematology·Mattia NovoUmberto Vitolo
Nov 23, 2019·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·María Queralt SalasEva González-Barca
Apr 8, 2020·Frontiers in Immunology·Mohammad MirzakhaniMousa Mohammadnia-Afrouzi
Feb 22, 2021·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Carla Isabelly Rodrigues-FernandesFelipe Paiva Fonseca